Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink

Abstract Background Human corneal endothelial cells lack regenerative capacity through cell division in vivo. Consequently, in the case of trauma or dystrophy, the only available treatment modality is corneal tissue or primary corneal endothelial cell transplantation from cadaveric donor which faces...

Full description

Bibliographic Details
Main Authors: Pyry Grönroos, Anni Mörö, Paula Puistola, Karoliina Hopia, Maija Huuskonen, Taina Viheriälä, Tanja Ilmarinen, Heli Skottman
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-024-03672-w
_version_ 1797220022005792768
author Pyry Grönroos
Anni Mörö
Paula Puistola
Karoliina Hopia
Maija Huuskonen
Taina Viheriälä
Tanja Ilmarinen
Heli Skottman
author_facet Pyry Grönroos
Anni Mörö
Paula Puistola
Karoliina Hopia
Maija Huuskonen
Taina Viheriälä
Tanja Ilmarinen
Heli Skottman
author_sort Pyry Grönroos
collection DOAJ
description Abstract Background Human corneal endothelial cells lack regenerative capacity through cell division in vivo. Consequently, in the case of trauma or dystrophy, the only available treatment modality is corneal tissue or primary corneal endothelial cell transplantation from cadaveric donor which faces a high global shortage. Our ultimate goal is to use the state-of-the-art 3D-bioprint technology for automated production of human partial and full-thickness corneal tissues using human stem cells and functional bioinks. In this study, we explore the feasibility of bioprinting the corneal endothelium using human pluripotent stem cell derived corneal endothelial cells and hydrazone crosslinked hyaluronic acid bioink. Methods Corneal endothelial cells differentiated from human pluripotent stem cells were bioprinted using optimized hydrazone crosslinked hyaluronic acid based bioink. Before the bioprinting process, the biocompatibility of the bioink with cells was first analyzed with transplantation on ex vivo denuded rat and porcine corneas as well as on denuded human Descemet membrane. Subsequently, the bioprinting was proceeded and the viability of human pluripotent stem cell derived corneal endothelial cells were verified with live/dead stainings. Histological and immunofluorescence stainings involving ZO1, Na+/K+-ATPase and CD166 were used to confirm corneal endothelial cell phenotype in all experiments. Additionally, STEM121 marker was used to identify human cells from the ex vivo rat and porcine corneas. Results The bioink, modified for human pluripotent stem cell derived corneal endothelial cells successfully supported both the viability and printability of the cells. Following up to 10 days of ex vivo transplantations, STEM121 positive cells were confirmed on the Descemet membrane of rat and porcine cornea demonstrating the biocompatibility of the bioink. Furthermore, biocompatibility was validated on denuded human Descemet membrane showing corneal endothelial -like characteristics. Seven days post bioprinting, the corneal endothelial -like cells were viable and showed polygonal morphology with expression and native-like localization of ZO-1, Na+/K+-ATPase and CD166. However, mesenchymal-like cells were observed in certain areas of the cultures, spreading beneath the corneal endothelial-like cell layer. Conclusions Our results demonstrate the successful printing of human pluripotent stem cell derived corneal endothelial cells using covalently crosslinked hyaluronic acid bioink. This approach not only holds promise for a corneal endothelium transplants but also presents potential applications in the broader mission of bioprinting the full-thickness human cornea.
first_indexed 2024-04-24T12:42:55Z
format Article
id doaj.art-bbde0b94d54f431f9cb4e9aba3e4f851
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-04-24T12:42:55Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-bbde0b94d54f431f9cb4e9aba3e4f8512024-04-07T11:10:34ZengBMCStem Cell Research & Therapy1757-65122024-03-0115112010.1186/s13287-024-03672-wBioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioinkPyry Grönroos0Anni Mörö1Paula Puistola2Karoliina Hopia3Maija Huuskonen4Taina Viheriälä5Tanja Ilmarinen6Heli Skottman7Faculty of Medicine and Health Technology, Tampere UniversityFaculty of Medicine and Health Technology, Tampere UniversityFaculty of Medicine and Health Technology, Tampere UniversityFaculty of Medicine and Health Technology, Tampere UniversityFaculty of Medicine and Health Technology, Tampere UniversityFaculty of Medicine and Health Technology, Tampere UniversityFaculty of Medicine and Health Technology, Tampere UniversityFaculty of Medicine and Health Technology, Tampere UniversityAbstract Background Human corneal endothelial cells lack regenerative capacity through cell division in vivo. Consequently, in the case of trauma or dystrophy, the only available treatment modality is corneal tissue or primary corneal endothelial cell transplantation from cadaveric donor which faces a high global shortage. Our ultimate goal is to use the state-of-the-art 3D-bioprint technology for automated production of human partial and full-thickness corneal tissues using human stem cells and functional bioinks. In this study, we explore the feasibility of bioprinting the corneal endothelium using human pluripotent stem cell derived corneal endothelial cells and hydrazone crosslinked hyaluronic acid bioink. Methods Corneal endothelial cells differentiated from human pluripotent stem cells were bioprinted using optimized hydrazone crosslinked hyaluronic acid based bioink. Before the bioprinting process, the biocompatibility of the bioink with cells was first analyzed with transplantation on ex vivo denuded rat and porcine corneas as well as on denuded human Descemet membrane. Subsequently, the bioprinting was proceeded and the viability of human pluripotent stem cell derived corneal endothelial cells were verified with live/dead stainings. Histological and immunofluorescence stainings involving ZO1, Na+/K+-ATPase and CD166 were used to confirm corneal endothelial cell phenotype in all experiments. Additionally, STEM121 marker was used to identify human cells from the ex vivo rat and porcine corneas. Results The bioink, modified for human pluripotent stem cell derived corneal endothelial cells successfully supported both the viability and printability of the cells. Following up to 10 days of ex vivo transplantations, STEM121 positive cells were confirmed on the Descemet membrane of rat and porcine cornea demonstrating the biocompatibility of the bioink. Furthermore, biocompatibility was validated on denuded human Descemet membrane showing corneal endothelial -like characteristics. Seven days post bioprinting, the corneal endothelial -like cells were viable and showed polygonal morphology with expression and native-like localization of ZO-1, Na+/K+-ATPase and CD166. However, mesenchymal-like cells were observed in certain areas of the cultures, spreading beneath the corneal endothelial-like cell layer. Conclusions Our results demonstrate the successful printing of human pluripotent stem cell derived corneal endothelial cells using covalently crosslinked hyaluronic acid bioink. This approach not only holds promise for a corneal endothelium transplants but also presents potential applications in the broader mission of bioprinting the full-thickness human cornea.https://doi.org/10.1186/s13287-024-03672-wBioprintingBioinkCorneaHuman pluripotent stem cellsCorneal endothelial cells
spellingShingle Pyry Grönroos
Anni Mörö
Paula Puistola
Karoliina Hopia
Maija Huuskonen
Taina Viheriälä
Tanja Ilmarinen
Heli Skottman
Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink
Stem Cell Research & Therapy
Bioprinting
Bioink
Cornea
Human pluripotent stem cells
Corneal endothelial cells
title Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink
title_full Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink
title_fullStr Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink
title_full_unstemmed Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink
title_short Bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink
title_sort bioprinting of human pluripotent stem cell derived corneal endothelial cells with hydrazone crosslinked hyaluronic acid bioink
topic Bioprinting
Bioink
Cornea
Human pluripotent stem cells
Corneal endothelial cells
url https://doi.org/10.1186/s13287-024-03672-w
work_keys_str_mv AT pyrygronroos bioprintingofhumanpluripotentstemcellderivedcornealendothelialcellswithhydrazonecrosslinkedhyaluronicacidbioink
AT annimoro bioprintingofhumanpluripotentstemcellderivedcornealendothelialcellswithhydrazonecrosslinkedhyaluronicacidbioink
AT paulapuistola bioprintingofhumanpluripotentstemcellderivedcornealendothelialcellswithhydrazonecrosslinkedhyaluronicacidbioink
AT karoliinahopia bioprintingofhumanpluripotentstemcellderivedcornealendothelialcellswithhydrazonecrosslinkedhyaluronicacidbioink
AT maijahuuskonen bioprintingofhumanpluripotentstemcellderivedcornealendothelialcellswithhydrazonecrosslinkedhyaluronicacidbioink
AT tainaviheriala bioprintingofhumanpluripotentstemcellderivedcornealendothelialcellswithhydrazonecrosslinkedhyaluronicacidbioink
AT tanjailmarinen bioprintingofhumanpluripotentstemcellderivedcornealendothelialcellswithhydrazonecrosslinkedhyaluronicacidbioink
AT heliskottman bioprintingofhumanpluripotentstemcellderivedcornealendothelialcellswithhydrazonecrosslinkedhyaluronicacidbioink